Delivery Order SPE2DB22D3019-SPE2DB24FK3FT
Award Date 4/17/24
Potential Completion Date 4/18/24
Potential Value $8.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $9,471.05 Firm Fixed Price delivery order is for the supply of the prescription drug Contrave ER 8-90 mg tablets. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $11,974.28 with a completion date of June 18, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the supply of the drug Contrave ER 8-90 mg tablet. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $12,488.58 Firm Fixed Price delivery order is for the provision of 4,564,742,861 units of the prescription drug Contrave ER 8-90 mg Tablet, with a completion date of May 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of the drug Contrave ER 8-90 mg tablets. The delivery order, valued at $5,367.46, is a firm-fixed-price contract with an ultimate completion date of October 24, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,610.08 firm fixed-price delivery order is for the provision of 120 tablets of the drug Contrave ER 8-90 mg. The contract has an ultimate completion date of April 5, 2024 and was awarded on April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $8,886.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Contrave ER 8-90 mg tablets, a medication used for weight management. The contract has a firm fixed price and an ultimate completion date of September 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,976.75 delivery order is for the supply of 120 tablets of the drug Contrave ER 8-90 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to DLA...
- This federal contract award, valued at $3,855.89, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This is a firm fixed price delivery order contract with a completion date of July 16, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large...
- This federal contract award is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Contrave ER 8-90 mg tablets. The $5,610.42 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 20, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,485.66 Firm Fixed Price Delivery Order contract is for the supply of Contrave ER 8/90mg 120 count medication. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...